Areas of Research
- Chemotherapy-Induced Neuropathy
- Chemotherapy-Induced Cognitive Impairments
- Chronic Pain
- Neuron-glia Interactions
The Neuroimmunology Laboratories are led by four well-funded, collaborative principal investigators who share space, equipment, and ideas to create a highly interactive, international, research-focused environment. The overall aim of these laboratories is to increase our understanding of the pathophysiology of cancer therapy-induced neurobehavioral toxicities, including neuropathic pain, depressed mood, cognitive dysfunction, and fatigue. This newly acquired knowledge can then be applied to the rational design of novel interventions for alleviating symptom burden in patients with cancer.
The Neuroimmunology Laboratories
Researching the pathophysiology of cancer therapy-induced neurobehavioral toxicities, including depressed mood, cognitive dysfunction and fatigue.
Discovering the adaptive immune mechanisms that initiate and maintain neuropathic pain after nerve injury.
Yuan Pan Lab
Providing insights into the prediction, prevention and treatment of nervous system cancer and neurological disorders.
Pain Research Symposium
ADVANCEMENTS IN TRANSLATIONAL SCIENCE FOR PAIN MANAGEMENT IN CANCER CARE: This symposium will connect you with MD Anderson clinical and basic science experts dedicated to ending pain for cancer patients and survivors. Engage in poster sessions, talks, and patient-caregiver panels to exchange insights and foster collaboration.May 10, 2024 – Learn More and Register
Did You Know?
The Neuroimmunology Laboratories are part of the Department of Symptom Research.
The labs extend the department's ongoing descriptive research and interventional trials by incorporating animal models of pain, fatigue, neuropathy, cognitive impairment, and the underlying neuroinflammatory mechansisms.